K-ras and p16INK4Aalterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers

作者: A Destro , P Bianchi , M Alloisio , L Laghi , S Di Gioia

DOI: 10.1016/J.LUNGCAN.2003.10.002

关键词:

摘要: Abstract NSCLC rates among the most frequent and lethal neoplasm world-wide a significant decrease in morbidity mortality relies only upon effective early diagnostic strategies. We investigated K-ras mutations p16 INK4A hypermethylation tumor tissue sputum of 50 patients with correlated them cytology staging, grading location, to ascertain, sputum, their potential impact. The same genetic/epigenetic abnormalities cytological features were also evaluated from 100 chronic heavy smokers. Genetic analysis identified molecular 64% tumors (14/50 24/50 hypermethylation) 48% (11/50 16/50 hypermethylation). In mostly mutually exclusive, being found 3 cases only. detected abnormal tumors. Molecular changes had detection similar (42%) but cyto-molecular combination increased yield up 60%. Interestingly, rate genetic at stage (T1) was not significantly different that more advanced (T2–T4). fact point frequently recognised while inactivation prevailed ( P =0.0063). As expected, findings =0.004). No correlation between location (central versus peripheral) changes. hypermethylation, mutations, documented sporadic asymptomatic smokers (4%) where it uncoupled abnormalities. conclusion strategy adopted this study able detect majority order be proposed as tool, panel needs tested prospective studies adequate follow-up.

参考文章(43)
LH Sobin, WD Travis, TV Colby, B Corrin, Y Shimosato, E Brambilla, Histological Typing of Lung and Pleural Tumours ,(1999)
Robyn Ward, Nicholas Hawkins, Roslynn O'Grady, Catherine Sheehan, Terence O'Connor, Helen Impey, Natalie Roberts, Caroline Fuery, Alison Todd, Restriction Endonuclease-Mediated Selective Polymerase Chain Reaction The American Journal of Pathology. ,vol. 153, pp. 373- 379 ,(1998) , 10.1016/S0002-9440(10)65581-2
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
S. Rodenhuis, S. S. Wagenaar, W. J. Mooi, A. J. M. Boot, R. J. C. Slebos, P. C. Van Bodegom, S. G. Evers, J. L. Bos, Incidence and Possible Clinical Significance of K- ras Oncogene Activation in Adenocarcinoma of the Human Lung Cancer Research. ,vol. 48, pp. 5738- 5741 ,(1988)
William N. Rom, Daniel R. Jacobson, Nancy E. Mills, Charles L. Fishman, Neil Dubin, Increased Prevalence of K-ras Oncogene Mutations in Lung Adenocarcinoma Cancer Research. ,vol. 55, pp. 1444- 1447 ,(1995)
Joseph Geradts, Jeffrey B. Rubins, Robert A. Kratzke, Todd M. Greatens, Dennis E. Niewoehner, Gloria A. Niehans, Michael A. Maddaus, Rb and p16INK4a Expression in Resected Non-Small Cell Lung Tumors Cancer Research. ,vol. 56, pp. 3415- 3420 ,(1996)
Christine A. Stidley, Frank D. Gilliland, William A. Palmisano, John F. Lechner, Steven A. Belinsky, Kevin K. Divine, Sally A. Winters, Richard E. Crowell, Marcie J. Grimes, Heidi J. Harms, Pam P. Moots, Carmen S. Tellez, Lida A. Crooks, Tammy M. Smith, Aberrant Promoter Methylation in Bronchial Epithelium and Sputum from Current and Former Smokers Cancer Research. ,vol. 62, pp. 2370- 2377 ,(2002)
Osuke Washimi, M Nagatake, Hirotaka Osada, Ryuzo Ueda, T Koshikawa, Tsuneo Seki, Toshitada Takahashi, Takashi Takahashi, In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers Cancer Research. ,vol. 55, pp. 514- 517 ,(1995)
Stephen L. Graziano, Gary P. Gamble, Nancy B. Newman, Lynn Z. Abbott, Michelle Rooney, Sulagna Mookherjee, Melissa L. Lamb, Leslie J. Kohman, Bernard J. Poiesz, Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 668- 668 ,(1999) , 10.1200/JCO.1999.17.2.668